Search
- Oct 19, 2023
Canaccord Genuity’s Bill Maughan joins BiotechTV for Analyst Thursdays
Bill Maughan discusses Nkarta, ESMO news on Bicycle, BioNTech, Olema, and Xencor, and comments on iPSC companies, Immmunocore, and more.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A